Despite associating ERα total protein levels with BCR, proteomics analyses did not distinguish between ERα levels in the different cells from the tumor microenvironment, nor did the analyses distinguish between active (nuclear) or inactive (cytoplasmic) receptors. This evidence concerns the gene ESR1 and neoplasm.